T2 Biosystems (NASDAQ:TTOO) reported Q2 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $5.9 million versus the consensus estimate of $6.14 million.
T2 Biosystems (NASDAQ:TTOO) reported Q2 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $5.9 million versus the consensus estimate of $6.14 million.